Sequoia Financial Advisors Adds $945K in Colgate-Palmolive Company ($CL)

The firm increased its holdings by 19.2%, now holding 64,773 shares worth $5.87 million.

Written by EarningsIQ · Published Jun 18, 2026, 4:50 AM EDT

Key Points

Sequoia Financial Advisors increased its stake in Colgate-Palmolive by 19.2%, adding 10,434 shares to total 64,773 shares as of the latest 13F filing.
Colgate-Palmolive, trading near $90.58, has a market cap of $72.48 billion and a forward P/E of 22.41, with a 52-week range between $74.55 and $99.33.
Recent insider transactions include multiple buys and sells, while analysts from firms like Bernstein and JP Morgan have maintained ratings with price targets up to $102.

Sequoia Financial Advisors has boosted its stake in Colgate-Palmolive Company (NYSE: CL) by 19.2% according to its latest filing with the SEC. The firm added 10,434 shares during the reporting period, bringing its total to 64,773 shares valued at approximately $5.87 million as of April 30, 2026.

What Changed in Sequoia Financial Advisors' Colgate-Palmolive Position

Sequoia Financial Advisors significantly increased its holdings in Colgate-Palmolive, adding 10,434 shares to its portfolio. This change represents a 19.2% increase, bringing their total holdings to 64,773 shares valued at about $5.87 million. This move suggests a strengthened confidence in Colgate-Palmolive's future prospects.

Other Institutional Activity in Colgate-Palmolive

Several other major institutional investors also adjusted their positions in Colgate-Palmolive. BlackRock, Inc. increased its holdings by 2,171,094 shares, resulting in a total of 72,643,002 shares valued at $6.19 billion. Price T Rowe Associates Inc /MD/ added 2,541,888 shares, bringing their total to 33,729,165 shares worth roughly $2.87 billion. Meanwhile, State Street Corp reduced its stake by 755,303 shares, leaving it with 47,719,482 shares valued at $4.07 billion.

Colgate-Palmolive Stock Snapshot

Shares of Colgate-Palmolive (NYSE: CL) recently traded near $90.58. The company has a market capitalization of $72.48 billion, with a P/E ratio of 35.11 and a forward P/E of 22.41. The stock's 52-week range spans from $74.55 to $99.33, with a 50-day moving average of $87.16 and a 200-day moving average of $84.38. Colgate-Palmolive's beta is a low 0.322, indicating less volatility compared to the broader market.

Recent Earnings

Colgate-Palmolive reported revenue of $20.8 billion, reflecting a growth rate of 8.4%. The company achieved a net margin of 10.0% and a return on equity of 3.64%. Earnings per share stood at $2.58. The next earnings report is anticipated on July 31, 2026.

Insider Buying and Selling at Colgate-Palmolive Company

Recently, several insiders have been active in trading Colgate-Palmolive shares. On June 16, 2026, COO Shane Grant sold 23,347 shares at an average price of $90.66. EVP and Controller Gregory Malcolm sold 2,300 shares on May 15, 2026, at $88.44. On May 11, 2026, insiders including Lisa Edwards and Kimberly Nelson each purchased 2,424 shares, while Brian Newman acquired 2,075 shares, all at no cost.

Analysts Set New Price Targets

Analysts have been updating their views on Colgate-Palmolive. On June 12, 2026, Bernstein initiated coverage with a 'hold' rating and a $96 price target. Barclays maintained a 'hold' rating with an $80 target on May 5, 2026. JP Morgan and UBS both maintained their 'buy' ratings on May 4, 2026, with price targets of $96 and $100, respectively. The consensus among 20 analysts is a 'buy' rating with a mean price target of $95.85.

About Colgate-Palmolive

Colgate-Palmolive Company, based in New York, NY, is a leading consumer products company operating globally. The company is known for its oral, personal, and home care products, as well as pet nutrition under brands like Colgate, Palmolive, and Hill's Science Diet. Led by CEO Noel R. Wallace, the company employs approximately 33,600 people worldwide.

Bottom Line

Sequoia Financial Advisors' increased stake in Colgate-Palmolive reflects a positive outlook on the company's potential. As a major player in the consumer products space, Colgate-Palmolive continues to attract attention from both institutional investors and analysts. It's important to note that 13F filings are historical and may not represent current positions.